MGMT-Unmethylated Glioblastoma — Trials

MGMT-Unmethylated Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Northwestern University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05694416	Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma	unknown	Phase 2	60	Zhongnan HospitalOTHER	0	Jan 23, 2023	clinicaltrials
NCT05033587	Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.	unknown	Phase 2	28	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER	1	Sep 5, 2021